Dow Up 0.07% Nasdaq Up 0.61%

Can-Fite BioPharma Ltd. (CANF)

-NYSE MKT
4.26 Up 0.32(8.12%) Nov 26, 4:01PM EST
|After Hours : 4.23 Down 0.03 (0.70%) Nov 26, 7:56PM EST
Prev Close:3.94
Open:4.04
Bid:4.04 x 300
Ask:4.37 x 300
1y Target Est:17.50
Beta:1.156
Next Earnings Date:N/A
Day's Range:3.95 - 4.45
52wk Range:2.29 - 9.46
Volume:835,830
Avg Vol (3m):331,678
Market Cap:37.68M
P/E (ttm):N/A
EPS (ttm):-0.89
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CANF

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.48
Quarterly EPS Est (Sep-14) :-0.13
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Can-Fite BioPharma, Ltd., a clinical-stage biotechnology company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and ophthalmic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback